C reactive protein impairs adaptive immunity in immune cells of patients with melanoma
Background High C reactive protein (CRP) levels have been reported to be associated with a poor clinical outcome in a number of malignancies and with programmed cell death protein 1 immune checkpoint blockade in patients with advanced cancer. Little is known about the direct effects of CRP on adapti...
Saved in:
| Main Authors: | Jeffrey Weber, Michelle Krogsgaard, Tatsuya Yoshida, Junya Ichikawa, Iulia Giuroiu, Andressa S Laino, Yuhan Hao, Melinda Vassallo, David M Woods, F Stephen Hodi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-05-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/8/1/e000234.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: C reactive protein impairs adaptive immunity in immune cells of patients with melanoma
Published: (2020-05-01) -
Advances in Cell and Immune Therapies for Melanoma
by: Tanase Timis, et al.
Published: (2025-01-01) -
Successful Management of Presumed Reactivation of Neospora caninum Following Immunosuppression for Immune Thrombocytopenia in an Adult Doberman
by: Perrine Henry, et al.
Published: (2025-07-01) -
Efficacy of immune checkpoint inhibitors for in-transit melanoma
by: Victoria Atkinson, et al.
Published: (2020-05-01) -
Targeting histone deacetylase 6 mediates a dual anti‐melanoma effect: Enhanced antitumor immunity and impaired cell proliferation
by: K.V. Woan, et al.
Published: (2015-08-01)